Immunovant PEG Ratio

Immunovant (IMVT) currently reports a PEG ratio of -58.19. That is below the Healthcare sector average of 2.89. Use the charts on this page to explore Immunovant's PEG ratio history and peer comparisons.

Immunovant's PEG ratio of -58.19 is lower than the Healthcare sector average of 2.89. That is roughly 2113.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Immunovant's market price to a fundamental measure such as earnings, sales, or book value. At -58.19, IMVT can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -58.19, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.89. From there, open related valuation or income-statement pages for Immunovant, and consider following IMVT for alerts when major investors trade the stock.

Immunovant is classified in the Healthcare sector. On PEG ratio, it currently shows -58.19 versus a sector average near 2.89. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMVT with unrelated industries.